James McCollum
Board Member
LENZ Therapeutics, Inc. (LENZ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James McCollum
James McCollum is recorded as Board Member at LENZ Therapeutics, Inc. (LENZ). LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that James McCollum was appointed Class I director, effective March 21, 2024.
“Effective as of the Effective Time, Frederic Guerard and James McCollum were appointed as Class I directors, Jeff George, Shelley Thunen, and Evert Schimmelpennink were appointed as Class II directors and Kimberlee C. Drapkin and Zach Scheiner were appointed as Class III directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at LENZ Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Evert Schimmelpennink CEO, Board Member
- Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
- Jeff George Chairman, Board Member
- Mr. George Chairman
- Daniel Chevallard CFO
- Katherine V. Stultz COO
- Continuing Directors Board Member
- Frederic Guerard Board Member
- Shelley Thunen Board Member
- Zach Scheiner Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.